Morgan Stanley’s PHARMACYCLICS INC PCYC Stock Holding History

Morgan Stanley’s Portfolio PCYC Stock Details PCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-485,957	Closed	-$124M	–	6960
2015 Q1	$124M	Sell	485,957 -45,765	-9%	-$8.84M	0.05%	422
2014 Q4	$65M	Sell	531,722 -28,816	-5%	-$3.68M	0.02%	716
2014 Q3	$65.8M	Buy	560,538 +11,814	+2%	+$1.35M	0.03%	700
2014 Q2	$49.2M	Buy	548,724 +59,618	+12%	+$5.59M	0.02%	808
2014 Q1	$49M	Buy	489,106 +219,338	+81%	+$28.5M	0.02%	753
2013 Q4	$28.5M	Buy	269,768 +36,562	+16%	+$4.44M	0.01%	1084
2013 Q3	$32.2M	Sell	233,206 -298,104	-56%	-$33.1M	0.02%	906
2013 Q2	$42.2M	Buy	+531,310	New	+$43.4M	0.02%	720

Other funds holding PCYC

Credit Agricole Montrouge Cedex, France $38.1B AUM

Morgan Stanley's PCYC Position: Q2 2015 in Review

Morgan Stanley sold out of PHARMACYCLICS INC (PCYC) in Q2 2015, closing a stake of 485,957 shares — an estimated $124M sold.

Morgan Stanley first reported a position in PCYC in Q2 2013 and held it in 8 quarters. The position peaked at $124M in Q1 2015. 1 fund tracked by Wall St. Rank holds PCYC as of Q2 2015.

Morgan Stanley reported no remaining PHARMACYCLICS INC position as of Q2 2015 after selling out during the quarter.
Morgan Stanley sold 485,957 PHARMACYCLICS INC shares in Q2 2015, an estimated $124M.
Morgan Stanley first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 8 quarters.
Morgan Stanley's PHARMACYCLICS INC position peaked at $124M in Q1 2015.
1 fund tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2015.

Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.